A detailed history of Rafferty Asset Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 90,427 shares of VCYT stock, worth $3.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
90,427
Previous 110,104 17.87%
Holding current value
$3.72 Million
Previous $2.39 Million 29.01%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.0 - $35.25 $413,217 - $693,614
-19,677 Reduced 17.87%
90,427 $3.08 Million
Q2 2024

Aug 13, 2024

SELL
$18.86 - $23.55 $3.74 Million - $4.67 Million
-198,455 Reduced 64.32%
110,104 $2.39 Million
Q1 2024

May 13, 2024

BUY
$21.0 - $29.1 $3.13 Million - $4.34 Million
149,094 Added 93.5%
308,559 $6.84 Million
Q4 2023

Feb 13, 2024

SELL
$19.72 - $28.68 $1.04 Million - $1.52 Million
-52,956 Reduced 24.93%
159,465 $4.39 Million
Q3 2023

Nov 13, 2023

SELL
$22.33 - $29.92 $691,805 - $926,951
-30,981 Reduced 12.73%
212,421 $4.74 Million
Q2 2023

Aug 11, 2023

SELL
$20.96 - $26.99 $992,330 - $1.28 Million
-47,344 Reduced 16.28%
243,402 $6.2 Million
Q1 2023

May 11, 2023

BUY
$20.58 - $27.89 $185,590 - $251,512
9,018 Added 3.2%
290,746 $6.48 Million
Q4 2022

Feb 13, 2023

SELL
$15.31 - $29.94 $978,140 - $1.91 Million
-63,889 Reduced 18.49%
281,728 $6.69 Million
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $2.43 Million - $4.09 Million
146,636 Added 73.69%
345,617 $5.74 Million
Q2 2022

Aug 12, 2022

SELL
$15.45 - $29.52 $398,331 - $761,084
-25,782 Reduced 11.47%
198,981 $3.96 Million
Q1 2022

May 13, 2022

BUY
$21.94 - $42.51 $1.98 Million - $3.84 Million
90,313 Added 67.17%
224,763 $6.2 Million
Q4 2021

Feb 10, 2022

BUY
$36.09 - $53.79 $2.54 Million - $3.79 Million
70,418 Added 109.97%
134,450 $5.54 Million
Q3 2021

Nov 10, 2021

SELL
$35.62 - $52.97 $290,053 - $431,334
-8,143 Reduced 11.28%
64,032 $2.97 Million
Q2 2021

Aug 10, 2021

BUY
$32.94 - $56.62 $285,952 - $491,518
8,681 Added 13.67%
72,175 $2.89 Million
Q1 2021

May 10, 2021

BUY
$44.47 - $81.38 $2.13 Million - $3.9 Million
47,928 Added 307.9%
63,494 $3.41 Million
Q4 2020

Feb 10, 2021

SELL
$32.49 - $61.88 $955,368 - $1.82 Million
-29,405 Reduced 65.39%
15,566 $762,000
Q3 2020

Nov 13, 2020

BUY
$26.73 - $35.67 $623,610 - $832,181
23,330 Added 107.8%
44,971 $1.46 Million
Q2 2020

Aug 07, 2020

BUY
$19.49 - $28.11 $421,783 - $608,328
21,641 New
21,641 $561,000
Q1 2020

May 15, 2020

SELL
$16.13 - $30.17 $878,730 - $1.64 Million
-54,478 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$20.78 - $29.99 $1.31 Million - $1.89 Million
-63,170 Reduced 53.69%
54,478 $1.52 Million
Q3 2019

Nov 14, 2019

BUY
$23.87 - $30.93 $703,854 - $912,032
29,487 Added 33.45%
117,648 $2.82 Million
Q2 2019

Aug 09, 2019

BUY
$22.1 - $28.56 $944,421 - $1.22 Million
42,734 Added 94.07%
88,161 $2.51 Million
Q1 2019

May 15, 2019

BUY
$12.0 - $25.76 $545,124 - $1.17 Million
45,427 New
45,427 $1.14 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.95B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.